The goals of the National Cancer Institute's Technology Transfer Center are to transfer knowledge, materials, and technologies to industry and university partners for translation into clinical products and to improve public health by facilitating the development of biomedical discoveries of NIH researchers. A needs assessment was undertaken using an online survey to gather data from managers and executives in companies with primary interest in biomedical areas and/or clinical research and development.
Nearly all respondents reported that their companies develop strategic technology partnerships. Those that did not form strategic technology partnerships were due to regulatory issues, geographic location, and lack of awareness of the possibility. Almost two thirds of respondents reported that their companies had or planned to have partnerships with off-shore organizations. Respondents also reported seeking off-shore partnerships at all commercialization stages, with the most common being basic research/discovery followed by preclinical and marketing and distribution. The most common reasons for seeking off-shore partnerships were to access expertise not available internally and to expand market reach. Evaluators determined a need to increase potential external customers' levels of familiarity with the institute's Technology Transfer Center.
Report Title: Evaluation of the National Cancer Institute Technology Transfer Center
Agency Sponsor: NIH, National Institutes of Health
Federal Contact: Rosanna Ng, 301-496-5367
Performer: The Madrillon Group Inc.; Nova Research Company
Record ID: 9874 (February 15, 2012)